Peru struggles to contain hepatitis B outbreak:
This article was originally published in Clinica
There has been a significant fall in the number of cases of hepatitis B reported so far this year in Peru, compared with the same period in 2001, but the health ministry remains on major alert. At the end of July 2002, the Peruvian health ministry's general office of epidemiology (OGE) reported 628 suspected cases, of which 356 had been confirmed, compared with 757 over the same period in 2001. The regions deemed at highest risk are Amazonas, Loreto, San Martin, Pasco, Ucayali, Cusco, Madre de Dios and Apurimac. The government has warned of the difficulty in diagnosing the disease and has launched a public awareness campaign and vaccination programme to help tackle the problem.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.